Caris Life Sciences, Inc. Common Stock CAI
$25.07
-0.99%
at last close
Market Cap$7.08 billion
P/E Ratio14.83
Div Yield4.79%
Volume4.71M
52-Week Range
$14.19$42.50
Analyst Ratings
- Consensus
- Moderate Buy — 6 Buy · 3 Hold · 0 Sell (9 analysts)
- Avg. Price Target
- $27.00 (+7.7% upside)
Key Stats
- Today's Range
- $24.47 – $25.14
- 50-Day Range
- $15.11 – $28.32
- 52-Week Range
- $14.19 – $42.50
- Volume
- 4.71 million shs
- Average Volume
- 5.47 million shs
- Market Cap
- $7.08 billion
- P/E Ratio
- 14.83
- Dividend Yield
- 4.79%
Valuation
- P/E Ratio
- 14.83
- Price / Book
- 11.97
- Price / Sales
- 7.16
Dividend
- Dividend Yield
- 4.79%
- Annual Dividend
- $1.20
- Payout Ratio
- 71.01%
- Ex-Dividend Date
- 2021-09-09
Short Interest
- Short Interest
- 0.13%
- Days to Cover
- 1.21
Financials (TTM)
- Revenue
- $989.61 million
- Net Income
- $105.14 million
- Net Margin
- 10.62%
- Return on Equity
- 17.77%
- Debt-to-Equity
- 0.66
About Caris Life Sciences, Inc. Common Stock
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
Related Stocks
Compare head-to-head: CAI vs NTRA·CAI vs DGX·CAI vs BLLN·CAI vs CDNA
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.